Some studies confirmed our observations, where elevated levels of this biomarker were detected in both blood and cerebrospinal fluid [22,28,29], while others showed no differences in CCL5 levels compared to controls or in patients with ischemic stroke over time [9,16,30]. This evidence concerns the gene CCL5 and ischemic stroke.